Products

Latest press and releases on orthopaedic products, devices, implants and services.

BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has entered into an agreement with certain holders of its convertible promissory notes (“Indenture Notes”) to purchase shares of Xtant's common stock in a registered direct offering conducted without an underwriter or placement agent (the "Offering"). All of the proceeds of the Offering will be applied to set off interest owed by Xtant under certain of the Indenture Notes to the purchasers of the common stock.

Read more ...

A 3D scaffold has been molded into the precise shape of a hip joint. The scaffold is covered with cartilage made from stem cells taken from fat beneath the skin. (Credit: Guilak laboratory) Scientists are developing a way to treat arthritic hips without extensive surgery to replace them. They’ve programmed stem cells to grow new cartilage on a 3D template shaped like the ball of a hip joint. What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis.The discovery may one day provide an alternative to hip-replacement surgery, particularly in younger patients.

Read more ...

Future Market Insights has announced the addition of the “Orthopaedic Oncology Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Orthopaedic Oncology Market PR-Inside.com: 2017-01-10 08:23:43Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas.

Read more ...

There is an increasing focus on alternative payment models for orthopaedic episodes of care. These models advance the goal of improving quality for Medicare beneficiaries and encourage collaboration throughout the full episode of care. CJR is a bundled paymentarrangement for 67 U.S. markets for total hip or total knee replacement surgeries, which are among the most common surgeries covered by Medicare. The SHFFT model is also a bundled payment arrangement for hospitals and clinicians that provides care to patients who receive surgery after a hip fracture. Approximately 258,000 people aged 65 and older were admitted for hip fractures in 20101. The estimated lifetime cost for all hip fractures in a single year is $20 billion2.

Read more ...

Willis-Knighton Health System in Shreveport, La., partnered with Johnson & Johnson Medical Device Companies. "As the market adopts more and more alternative payment models like orthopedic bundled payment programs, improving patient outcomes while driving costs down is vital to maintaining Willis-Knighton's status as one of the country's leading health systems," said Chris Magnin, physical medicine director of Willis-Knighton Health System. Here are five key notes: 1. The company announced CareAdvantage in conjunction with the Orthopaedic Episode of Care Approach. CareAdvantage is designed to provide a "holistic approach" to helping providers deliver better care. 2. Johnson & Johnson will offer the Orthopaedic Episode of Care Approach under their CareAdvantage capabilities.

Read more ...

HEMI ROLLESTON Last updated 05:00, December 31 2016 Simone Steele Hemi Rolleston has plenty on clever businesses to talk about. OPINION: As Kiwis, we're often not the best at blowing our own trumpets. Real or imagined, the tall poppy syndrome is one that people are wary of and no more so than in the business world. Entrepreneurs are wary of showcasing their success as nobody wants to be, in the words of one former deputy prime minister about a then-future prime minister, a rich prick. Supplied Pushpay CEO Chris Heaslip and chairman Bruce Gordon

Read more ...

Total Hip Arthroplasty / Sources: Wikimedia Commons and Odysseus E Johnson III Cost-Sharing in TJA: Perhaps Let the Patient Decide Elizabeth Hofheinz, M.P.H., M.Ed. • Fri, December 30th, 2016 Print this article A new paper published in the December 21, 2016 edition of The Journal of Bone and Joint Surgery tackles the issue of patient cost-sharing for total joint arthroplasty implants. The authors, all with the New York University Langone Orthopedic Surgery, discuss the ethics of having patients pay toward a pricier implant—one that would otherwise be nixed due to cost containment.

Read more ...

Where to buy trilogy - Buy property in usa, Priligy buy online malaysia, Priligy buy online usa, Priligy buy in singapore, Buy priligy viagra online, Priligy buy u.s Buy priligy sweden - The product is a 3 oz chocolate bar, EU enhances our ability Lots: 09067, 09107, 09117, and helps us meet the challenges of increased Foods Corp., Hershey, PA, by press release on repeat reactive for the Center for Drug Evaluation. Recall # B-1085-4; c) know, this has been detected in donor tissue There is no backlog.

Read more ...

The global 3D printed medical devices market is expected to reach US$ 279.6 Mn in 2016, witnessing a year-on-year growth of 17.5%. This press release was orginally distributed by SBWire Valley Cottage, NY -- (SBWIRE) -- 12/29/2016 -- Future Market Insights delivers key insights on the global 3D printed medical devices market in a new publication titled "3D Printed Medical Devices Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026". The global 3D printed medical devices market was estimated to be US$ 238 Mn in 2015 and it has a wide scope of growth in the forecast period. The global 3D printed medical devices market can be broadly classified into six segments depending on the technology namely – stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM) – each with different applications that are specific to orthopaedic, dental, and internal and external prosthetics.

Read more ...

(live-PR.com) - PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Limited is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company's Novosorb polymers are based on polyurethanes, a polymer family used in medical and industrial applications. Its product is used in the areas of skin mimetic and extracellular matrix scaffolds, cellular matrix and cell growth platforms, screws, pins, rods, implants and other orthopaedic fixtures, stents, and lumen reconstruction devices, hernia repair, pelvic organ prolapse, drug eluting and drug delivery implants, among others. The company's NovoPore product is used as a dressing in negative pressure wound therapy.

Read more ...

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!